TSVT
2seventy bio
2seventy bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Company Sector
Oncology
106 companies tagged with Oncology.
Oncology covers companies developing therapies, diagnostics, and enabling technologies for cancer. On BioPharmSignal, this sector page groups businesses tied to solid tumors, hematologic malignancies, precision oncology, immuno-oncology, and other cancer-focused programs.
ACRV
Acrivon Therapeutics
Acrivon Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ADCT
ADC Therapeutics
ADC Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ANL
Adlai Nortye Ltd.
阿诺医药 is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ALLR
Allarity Therapeutics
Allarity Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
DRTS
Alpha Tau Medical
Alpha Tau Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
ALXO
ALX Oncology
ALX Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
ALXN
ALXN
ALXN is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
AMGN
Amgen Inc.
Amgen is a large-cap biopharmaceutical company with a commercial base spanning oncology, inflammation, bone health, cardiovascular disease, and rare disease. Investors follow the stock for the mix of marketed products, late-stage pipeline optionality, and recurring regulatory or launch milestones.
APVO
Aptevo Therapeutics
Aptevo Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
APTO
Aptose Biosciences, Inc.
Aptose Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ARGX
Argenx
Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
AZN
AstraZeneca PLC
AstraZeneca is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ATRA
Atara Biotherapeutics, Inc.
Atara Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Aura
Aura Biosciences
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
AURA
Aura Biosciences
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
BIOC
Biocept
Biocept is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BNTX
BioNTech
BioNTech is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BTAI
BioXcel
BioXcel is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BMY
BMYBristol-Myers Squibb Company
Bristol Myers Squibb is a large-cap biopharmaceutical company with a portfolio spanning oncology, hematology, immunology, and cardiovascular disease. The market watches the stock for commercial durability, pipeline replacement, and the pace at which new assets offset lifecycle pressure.
BCLI
Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
CADL
Candel Therapeutics
Candel Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CRDF
Cardiff Oncology
Cardiff Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
RNAC
Cartesian Therapeutics
Cartesian Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
CELG
CELG
CELG is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
IPSC
Century Therapeutics
Century Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CGON
CG Oncology, Inc.
CG Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
CSBR
Champions Oncology
Champions Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
CKPT
Checkpoint Therapeutics
Checkpoint Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CRBP
Corbus Pharmaceuticals
Corbus Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CGEM
Cullinan Therapeutics, Inc.
Cullinan Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CVAC
CureVac
CureVac is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
DARE
Dare Bioscience, Inc.
Dare Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
DECI
Decipher Biosciences
Decipher Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
DCTH
Delcath Systems
Delcath Systems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ELEV
Elevation Oncology
Elevation Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
LLY
Eli Lilly
Eli Lilly is a large-cap pharmaceutical company with major exposure to cardiometabolic disease, neuroscience, and oncology. Investors track the stock for commercial scale, label expansion, and a pipeline that still carries meaningful growth optionality.
ELVN
Enliven Therapeutics
Enliven Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ERAS
Erasca
Erasca is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
EXEL
Exelixis
Exelixis is an oncology-focused biopharmaceutical company best known for its established commercial base and continued pipeline work in cancer. Investors follow the stock for launch durability and the next wave of oncology catalysts.
FUSN
Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
GMDA
Gamida Cell
Gamida Cell is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
GMAB
Genmab
Genmab is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
GILD
Gilead Sciences
Gilead Sciences is a large-cap biopharmaceutical company with a commercial base anchored by antivirals and a growing set of oncology and inflammation programs. Investors track the balance between cash flow strength, launch execution, and pipeline replacement.
GSK
GSK plc
GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
GH
Guardant Health
Guardant Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
HARP
Harpoon Therapeutics
Harpoon Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
IMAB
I-MABDR
I-MABDR is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ICCM
IceCure Medical
IceCure Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
IDYA
IDEAYA Biosciences
IDEAYA Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
IKNA
Ikena Oncology
Ikena Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
INDP
Indaptus Therapeutics
Indaptus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
INBX
Inhibrx
Inhibrx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
INO
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
TIL
Instil Bio
Instil Bio is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
IOVA
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics is a commercial-stage cell therapy company focused on tumor-infiltrating lymphocyte, or TIL, therapies for solid tumors. The company's story is centered on turning a complex personalized treatment approach into a scalable oncology franchise, with investors watching launch execution, adoption, and the broader expansion of the TIL platform.
ITOS
iTeos Therapeutics
iTeos Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
JNJ
Johnson & Johnson
Johnson & Johnson is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
KZIA
Kazia Therapeutics Limited
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
KRON
Kronos Bio
Kronos Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
KURA
Kura Oncology
Kura Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
LADX
LadRx
LadRx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
LPTX
Leap Therapeutics
Leap Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
LCTX
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
MKT
Maia Biotechnology
Maia Biotechnology is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
MRKR
Marker Therapeutics
Marker Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
MDNA
Medicenna Therapeutics Corp.
Medicenna Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
MRK
Merck
Merck is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
MRNA
Moderna, Inc.
Moderna is an mRNA medicines company that built its platform around vaccine science and is now broadening into infectious disease, oncology, and other therapeutic areas. Investors watch how the company converts platform credibility into a wider commercial story.
MURA
Mural Oncology
Mural Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
NAUT
Nautilus Biotechnology
Nautilus Biotechnology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
NKTR
Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NKGN
NKGen Biotech, Inc.
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NWBO
Northwest Biotherapeutics
Northwest Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NRIX
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NUVB
Nuvation Bio
Nuvation Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ONCR
Oncorus
Oncorus is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
PBLA
Panbela Therapeutics
Panbela Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CATX
Perspective Therapeutics
Perspective Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
PFE
Pfizer, Inc.
Pfizer is a global pharmaceutical company with a diversified portfolio across vaccines, internal medicine, oncology, and other specialty areas. Investors track the stock for commercial scale, pipeline renewal, and the pace at which major programs translate into growth.
PHIO
Phio Pharmaceuticals
Phio Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
POAI
Predictive Oncology
Predictive Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
PPBT
Purple Biotech
Purple Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
PYXS
Pyxis Oncology
Pyxis Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
RAPT
RAPT Therapeutics
RAPT Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
REGN
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biologics-driven biopharmaceutical company built around antibody science, specialty-market execution, and a durable R&D engine. Investors watch both the commercial base and the next wave of pipeline readouts.
RPTX
Repare Therapeutics
Repare Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
RVMD
Revolution Medicines
Revolution Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SNY
Sanofi
Sanofi is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SPPI
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
SWTX
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
SURF
Surface Oncology
Surface Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
STRO
Sutro Biopharma
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
SNDX
Syndax Pharmaceuticals
Syndax Pharmaceuticals is an oncology company focused on targeted therapies and hematologic disease opportunities. Investors watch trial readouts, regulatory milestones, and how the company converts its pipeline into commercial traction.
TCMD
Tactile Systems Technology, Inc.
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
TAK
Takeda
Takeda is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
TCRR
TCR² Therapeutic
TCR² Therapeutic is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
TLSA
Tiziana Life Sciences
Tiziana Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
RNAZ
TransCode Therapeutics, Inc.
TransCode Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
VAR
Varian Medical Systems
Varian Medical Systems is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
VERU
Veru Inc
VERU is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
VOR
Vor Biopharma
Vor Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
HOWL
Werewolf Therapeutics
Werewolf Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
XLO
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
YMAB
Y-mAbs
Y-mAbs is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ZLAB
Zai Lab Limited
Zai Lab Limited is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.